The Board of Directors of PharmaCyte Biotech, Inc has authorized a buyback plan on May 11, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | +1.08% | +4.27% | +1.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.85% | 18.4M | |
+31.10% | 695B | |
+26.51% | 568B | |
-4.60% | 361B | |
+19.57% | 330B | |
+3.76% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+9.15% | 168B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc authorizes a Buyback Plan.